UPL Limited (NSE: UPL | BSE: 512070)

By Raveendran R | Updated on:

Source: UPL Limited Annual Report [FY 2025-26 / Fiscal Year Ended March 31, 2026]

Metrics for FY 2025-26 Ended Mar 31, 2026
Profit & Loss (₹ Cr)
Revenue
₹51,839.00 Cr (▲ 11.2%)
Prev Year: ₹46,637.00 Cr
Gross Profit
₹24,103.00 Cr (▼ 0.2%)
Prev Year: ₹24,140.00 Cr
Operating Profit
₹6,344.00 Cr (▲ 18.0%)
Prev Year: ₹5,374.00 Cr
Net Profit
₹2,220.00 Cr (▲ 170.7%)
Prev Year: ₹820.00 Cr
Ratios & Margins (% / x)
Gross Margin
46.50 % (▼ 527 bps)
Prev Year: 51.76 %
Operating Margin
12.24 % (▲ 71 bps)
Prev Year: 11.52 %
PAT Margin
4.28 % (▲ 252 bps)
Prev Year: 1.76 %
ROCE
10.49 % (▲ 145 bps)
Prev Year: 9.04 %
ROCE (5Y Avg)
11.07 %
FY22–FY26 (5Y Avg)
ROE
5.38 % (▲ 321 bps)
Prev Year: 2.17 %
ROA
2.33 % (▲ 140 bps)
Prev Year: 0.93 %
Asset Turnover
0.54x (▲ 0.01 pts)
Prev Year: 0.53x
Balance Sheet (₹ Cr)
Total Assets
₹95,205.00 Cr (▲ 8.2%)
Prev Year: ₹88,002.00 Cr
Current Assets
₹42,162.00 Cr (▲ 6.4%)
Prev Year: ₹39,617.00 Cr
Total Liabilities
₹53,936.00 Cr (▲ 7.5%)
Prev Year: ₹50,176.00 Cr
Current Liabilities
₹34,748.00 Cr (▲ 21.6%)
Prev Year: ₹28,569.00 Cr
Total Debt
₹6,511.00 Cr (▲ 19.4%)
Prev Year: ₹5,451.00 Cr
Total Equity
₹41,269.00 Cr (▲ 9.1%)
Prev Year: ₹37,826.00 Cr
Working Capital
₹7,414.00 Cr (▼ 32.9%)
Prev Year: ₹11,048.00 Cr
Ratios & Margins (% / x)
Current Ratio
1.21x (▼ 0.17 pts)
Prev Year: 1.39x
Debt to Equity
0.16x (▲ 0.01 pts)
Prev Year: 0.14x
Debt to Assets
0.07x (▲ 0.01 pts)
Prev Year: 0.06x
Equity Multiplier
2.31x (▼ 0.02 pts)
Prev Year: 2.33x
Cash Flow (₹ Cr)
Operating Cash Flow
₹7,855.00 Cr (▼ 22.6%)
Prev Year: ₹10,151.00 Cr
CapEx
₹2,406.00 Cr (▲ 41.9%)
Prev Year: ₹1,695.00 Cr
Free Cash Flow
₹5,449.00 Cr (▼ 35.6%)
Prev Year: ₹8,456.00 Cr
Ratios & Margins (% / x)
FCF Margin
10.51 % (▼ 762 bps)
Prev Year: 18.13 %
Cash ROCE
12.99 % (▼ 409 bps)
Prev Year: 17.08 %
Cash ROE
19.03 % (▼ 780 bps)
Prev Year: 26.84 %
CF to Debt
1.21x (▼ 0.66 pts)
Prev Year: 1.86x

📋 Quick Facts: Company Snapshot

Attribute Disclosed Detail
Official Company Name UPL Limited
Corporate Identity Number (CIN) L24219GJ1985PLC025132
ISIN INE628A01036 (Equity Shares of ₹ 2/- each Fully paid-up)
NSE Symbol & BSE Scrip Code NSE: UPL | BSE: 512070
Date of Incorporation / Founding Year 1985 (Over 50 years of operating legacy)
Registered Office 3-11, G.I.D.C., Vapi, Dist. Valsad – 396 195, Gujarat, India
Corporate Headquarters Uniphos House, C.D. Marg, 11th Road, Madhu Park, Khar (West), Mumbai – 400 052, Maharashtra, India
Telephone & Investor Relations Contact Telephone: +91 22 7152 8000 / +91 22 6856 8000; Email: upl.investors@upl-ltd.com / contact@upl-ltd.com
Chairman / Managing Director & CEO Mr. Jaidev R. Shroff (Chairman & Group CEO)
Chief Financial Officer (CFO) & Company Secretary (CS) Mr. Bikash Prasad (Group Chief Financial Officer) & Mr. Sandeep Deshmukh (Company Secretary and Compliance Officer, ACS-10946)
Promoter & Holding Group Promoter & Promoter Group (33.09% equity holding; led by Jaidev R. Shroff and Vikram R. Shroff)
Industry / Sector Classification Agrochemicals, Seeds, Post-Harvest Solutions & Specialty Chemicals
Total Employees / Permanent & Contractual Workforce (BRSR) 12,399 Global Employees (Standalone BRSR: 596 Permanent Employees, 286 Permanent Workers; Total 882)
Manufacturing Plants / Branches / Offices Count 43 Global Manufacturing Facilities (including 9 Technical Plants in India) | 25 Global R&D Hubs | 74 Indian Operating Locations (3 Plants, 71 Offices)
Countries / States Served Presence in >140 Countries globally; Domestic presence across 21 Indian States and Union Territories
Statutory Auditors B S R & Co. LLP, Chartered Accountants (ICAI Firm Registration No. 101248W/W-100022)
Registrar and Share Transfer Agent (RTA) MUFG Intime India Private Limited, C-101, 247 Embassy Park, LBS Marg, Vikhroli (West), Mumbai – 400 083

🏢 The Corporate Identity: Who They Are & Where They Came From

The Big Picture

UPL Limited is a globally integrated producer and distributor of sustainable agricultural solutions, hybrid seeds, biological inputs, and specialty chemicals. Anchored by its corporate vision “to be a global icon for technology growth and innovation” and guided by its mission “to change the game, to make every single food product more sustainable,” the enterprise ranks as the fifth-largest crop protection player globally and the tenth-largest global seeds powerhouse. Headquartered in Mumbai, India, the Group operates across the entire agrarian continuum from pre-planting soil conditioning, elite germplasm deployment, and active crop protection formulations to specialized post-harvest storage technologies.

The company executes its commercial strategy through a diversified operational structure across Latin America, North America, Europe, India, and the Rest of the World. Operating in more than 140 countries with an annual consolidated turnover exceeding ₹51,800 crore, UPL leverages proprietary chemical synthesis, high-yielding hybrid germplasm, and biological mechanisms to shield growers from climatic and economic volatility while addressing global food security challenges.

  • Global Crop Protection Scale: Ranks as the 5th largest crop protection manufacturer globally, commanding more than 16,000 registrations and marketing over 2,000 distinct commercial products across global row crops and specialty horticulture.
  • Global Seeds Positioning: Operates as the 10th largest seed company globally through its subsidiary Advanta Enterprises Limited, maintaining a commercial catalog exceeding 900 active hybrids spanning 40 major agricultural crops.
  • Comprehensive ESG Leadership: Ranked #1 agrochemical company globally in ESG by the Dow Jones Sustainability Index (DJSI) with an S&P Global Corporate Sustainability Assessment score of 77 out of 100, securing placement in the DJSI World Index for three consecutive years.
  • Manufacturing Footprint Moat: Houses 43 manufacturing sites globally linked via vertical backward integration, with 9 Indian technical synthesis plants supplying key active ingredients and high-grade specialty intermediaries to domestic and offshore downstream formulation hubs.

The Founders, Promoters & Their Legacy

The institutional lineage of UPL Limited was founded by Chairman Emeritus Rajnikant D. Shroff, who pioneered indigenous chemical synthesis and agrochemical active ingredient manufacturing in India over five decades ago. Under his industrial stewardship, the company expanded from a single domestic manufacturer into a multibillion-dollar multinational agricultural conglomerate, breaking historic reliance on imported chemical active ingredients and advancing accessible crop protection tools for emerging market growers.

The contemporary strategic direction of UPL is led by Mr. Jaidev R. Shroff, Chairman and Group CEO, alongside Mr. Vikram R. Shroff, Vice-Chairman and Co-CEO. Together with the broader Promoter and Promoter Group, which holds a 33.09% equity stake in the parent entity as of March 31, 2026, the leadership team steered the transition of the company from a conventional generic supplier into a differentiated, innovation-focused agricultural platform underpinned by proprietary technologies, environmental stewardship, and institutional partnerships through platforms such as the World Economic Forum and COP30.

The Journey: History & Evolution

Incorporated under the Companies Act in 1985 as an Indian chemical manufacturer, UPL systematically assembled global operational capabilities through organic investments and landmark cross-border business combinations. A major inflection occurred with the transformational acquisition of Arysta LifeScience, which established the company’s international crop protection presence across Europe, the Americas, and Africa, while introducing its proprietary Natural Plant Protection (NPP) biological platform and ProNutiva programs.

In FY 2025-26, the company marked an operational and financial recovery following an eighteen-month cyclical downturn across the global crop protection sector characterized by post-COVID supply chain channel destocking, generic oversupply from China, and depressed active ingredient prices. UPL successfully executed a structural transformation by carving out and scaling distinct pure-play platforms, lowering its net debt-to-EBITDA leverage to 1.6x, and initiating capital structure reorganizations to unlock long-term shareholder value.

  • 1985–2010s (Industrial Scale-Up): Engineered backward-integrated chemical complexes in Gujarat, expanding into phosphorus, cynation, acrolein, and phosgenation chemistries, complemented by global registrations and export market penetrations.
  • Arysta Acquisition & NPP Platform: Scaled high-margin biologicals, biocontrols, and biostimulants through the integration of Arysta LifeScience, consolidating its position in multi-site contact fungicides and differentiated formulations.
  • January 2026 (Advanta DRHP Filing): Subsidiary Advanta Enterprises Limited filed its Draft Red Herring Prospectus (DRHP) on January 19, 2026, with SEBI, BSE, and NSE for a proposed Initial Public Offering via an Offer for Sale of up to 3,61,05,578 equity shares.
  • February 2026 (Composite Scheme of Arrangement): The Board of Directors approved a group reorganisation involving the amalgamation of UPL SAS into UPL Limited, the demerger of the combined Indian and International Crop Protection businesses into UPL Global Sustainable Agri Solutions Limited, and its subsequent independent public listing.

The Corporate Umbrella

The operational and corporate architecture of UPL Limited is organized around four distinct pure-play commercial platforms, designed to sharpen strategic focus, optimize platform-level capital structures, and remove holding-company valuation discounts. These businesses operate with dedicated executive management teams while sharing centralized manufacturing infrastructure, chemical R&D centers, global treasury functions, and modern Global Capability Centres (GCCs).

The international crop protection business is executed through UPL Corporation Limited (Mauritius / Cayman Islands), while domestic Indian crop protection operations are managed via UPL Sustainable Agri Solutions Limited (UPL SAS). The hybrid seeds and post-harvest preservation segment operates under Advanta Enterprises Limited (consolidating Advanta Seeds and DECCO Post-Harvest solutions). The specialty chemicals and custom synthesis contract manufacturing segment is anchored under SUPERFORM Chemistries Limited.

  • UPL Corporation Ltd. (International Crop Protection): Focuses on global agricultural regions across LATAM, North America, Europe, and Asia-Pacific, delivering differentiated crop protection, ProNutiva combination packages, and NPP BioSolutions.
  • UPL Sustainable Agri Solutions Ltd. (UPL SAS – India Crop Protection): Drives domestic crop protection distribution, channel partner networks, direct-to-retail B2B e-commerce through nurture.farm, and precision agronomic spraying services across India.
  • Advanta Enterprises Limited (Global Seeds & Post-Harvest): Operates elite breeding and germplasm research across 40 crops—specializing in field corn, grain sorghum, sunflower, canola, and fresh vegetables—fully integrated with DECCO’s post-harvest coatings and shelf-life preservation chemistries.
  • SUPERFORM Chemistries Limited (Specialty Chemistries): Handles complex chemical synthesis, including phosgenation, cynation, phosphorus derivatives, and acrolein, providing high-efficiency solutions to over 50 downstream industries alongside contract manufacturing (CMO) exports.

⚙️ The Business Engine: What They Do & Where They Operate

The Core Divisions

Under Indian Accounting Standard (Ind AS) 108 on Operating Segments, the Group’s reportable primary operating segments are Crop Protection, Seeds & Post-Harvest Solutions, and Non-Agro (Specialty and Industrial Chemistries). During FY 2025-26, the Group executed an internal structural realignment by shifting its DECCO post-harvest treatment operations from the Crop Protection segment into the Seeds & Post-Harvest Solutions segment, reflecting commercial synergies between seed genetics and food shelf-life preservation. Segment comparative figures for FY 2024-25 were restated accordingly.

The Crop Protection division accounted for the majority of top-line revenue, benefiting from strong volume recoveries in herbicides and fungicides across North America, Europe, and Brazil. The Seeds & Post-Harvest Solutions division achieved rapid revenue and profitability expansion driven by global field corn adoption, while the Non-Agro platform expanded its super specialty chemistries portfolio to supply non-agricultural industrial applications.

Reportable Segment (Ind AS 108) FY 2025-26 Segment Revenue (₹ in Crores) % Share of Total Revenue FY 2025-26 Segment Results / PBIT (₹ in Crores) FY 2025-26 Segment Assets (₹ in Crores) FY 2025-26 Segment Liabilities (₹ in Crores)
Crop Protection 42,206 81.42% 5,738 70,194 23,684
Seeds & Post-Harvest Solutions 6,830 13.18% 1,425 8,107 2,847
Non-Agro (Specialty Chemistries) 2,803 5.41% 344 2,162 551
Intersegment Elimination (193) (0.37%) – – –
Unallocated / Corporate – – (4,350) 14,742 26,854
Total Consolidated 51,839 100.00% 3,157 (PBT) 95,205 53,936

The unallocated reconciliation from total segment results (₹7,507 crore) to Consolidated Profit Before Tax (₹3,157 crore) comprises Net Finance Costs of ₹3,401 crore, unallocable corporate depreciation and amortisation of ₹816 crore, share of loss of associates and joint ventures of ₹194 crore, offset by net exceptional items gain of ₹61 crore.

The Product & Service Catalog

The product portfolio of UPL Limited covers basic technical chemical synthesis, multi-action pre-mix formulations, advanced biologicals, elite seeds, and industrial intermediates. As disclosed in the Business Responsibility and Sustainability Report (BRSR), the standalone business generates 83.20% of its turnover from the manufacture of Chemical & Chemical Products (NIC Code: 2021) and 16.80% from Wholesale Trading activities.

Across the consolidated enterprise, crop protection sales are distributed across five primary product categories: Herbicides, Insecticides & Acaricides, Fungicides, NPP BioSolutions, and Specialized Adjuvants/Fumigants/Public Health solutions. In seeds, the product mix is led by Field Corn, Grain & Forage Sorghum, Sunflower & Canola, and Fresh Vegetables.

  • Herbicides (38% of Crop Protection Sales | ₹1,432.50 Crore): Selective and non-selective formulations designed for broadacre row crops. Key chemical entities include clethodim, s-metolachlor, metribuzin, glufosinate, and bixlozone. Flagship brands include Winger, Preview, Interline, Moccasin, and Lifeline.
  • Fungicides (26% of Crop Protection Sales | ₹999.80 Crore): Broad-spectrum protective and systemic disease control formulations combating Asian soybean rust and cereal blights. Core brands include Unizeb Gold, Disarm, Manzate, Evolution, Proxanil, Cuprofix Ultra, and Saaf.
  • Insecticides & Acaricides (23% of Crop Protection Sales | ₹884.50 Crore): Chemical and biological pest management tools targeting sucking insects and lepidoptera complexes. Core brands include Propose, Feroce, Perito, Constel, Sperto, Ulala, Lancer Gold, and Shenzi.
  • NPP BioSolutions (11% of Crop Protection Sales | ₹4,276 Crore): Naturally derived biocontrols, biostimulants, bionematicides, and nutritional solutions. Key platforms include Vacciplant, Goemar GA142, Biozyme, and the Nuvita foliar nitrogen-use efficiency platform.
  • Hybrid Seeds & Post-Harvest Preservation (₹683.70 Crore Total Advanta Revenue): Commercial hybrid seed portfolio comprising field corn (40% of Advanta revenue), sorghum (16%), sunflower & canola (15%), vegetables and fresh corn (10%), alongside DECCO post-harvest anti-fungal coatings and storage waxes (17%).
  • SUPERFORM Specialty Chemistries (₹10,298 Crore Revenue): High-performance chemical synthesis specializing in phosphorus derivatives, phosgenation, cynation, and acrolein for flame retardants, lubricant additives, mining chemicals, polymers, and pharmaceuticals.

The Names You Know

UPL has established commercial brand equity across mature and emerging agricultural basins. These proprietary trademarks and technological brand architectures support farmer customer loyalty and premium price positioning over unbranded generic alternatives.

  • ProNutiva: An integrated crop management architecture that combines biological inputs (biocontrols, biostimulants, soil amendments) with conventional crop protection formulations to boost yields, mitigate abiotic stress, and lower chemical residue levels.
  • Nuvita / Nutreo: A specialized foliar plant nutrition and nitrogen-use efficiency technology platform deployed across Brazil, Argentina, and Southeast Asia to optimize nutrient absorption and decrease reliance on synthetic chemical fertilizers.
  • igrowth: The world’s first commercial herbicide-tolerant sorghum seed technology, enabling over-the-top application of imidazolinone herbicides to eliminate grass and broadleaf weeds without crop damage.
  • aphix: Proprietary seed trait packages conferring tolerance against sugarcane aphid pests in grain and forage sorghum hybrids.
  • Vertix: Patented high-oleic and high-stearic sunflower germplasm delivering three times the oleic acid and four times the stearic acid of conventional sunflower varieties.
  • nurture.farm: A digital agriculture and rural commerce ecosystem in India supporting more than 2.5 million farmers and 1,15,000 retailers with mechanization bookings, advisory services, and digital input supply.

Mapping the Domestic & Global Reach

UPL maintains a geographically balanced commercial footprint spanning all major agricultural continents. International markets generate approximately 88% of total consolidated operational revenue, while the domestic Indian market accounts for the remaining 12%. This geographical diversification hedges the business against regional weather disruptions, local monsoon deficits, and territory-specific regulatory changes.

Geographic Region FY 2024-25 Revenue (₹ in Crores) FY 2025-26 Revenue (₹ in Crores) % Share of FY26 Revenue Latest YoY (%)
Latin America (LATAM) 17,600 19,358 37.34% +9.99%
Rest of the World (ROW) 9,832 10,789 20.81% +9.73%
Europe 7,189 8,167 15.75% +13.60%
North America (NAM) 6,065 7,182 13.85% +18.42%
India (Domestic) 5,951 6,343 12.24% +6.59%
Total Consolidated Revenue 46,637 51,839 100.00% +11.15%

Latin America remains the company’s largest regional market, generating ₹19,358 crore (37.34% of sales), driven by broadacre soybean and field corn applications in Brazil and weed management programs in Argentina. North America demonstrated the fastest regional recovery, expanding 18% YoY to ₹7,182 crore as channel distributors completed inventory destocking and replenished branded herbicides and fungicides. Europe grew 14% to ₹8,167 crore supported by favorable early cereal disease pressure and currency tailwinds from the Euro, while Rest of the World operations delivered 10% growth to ₹10,789 crore on strong traction in Southeast Asia and South Africa.

The Brick & Mortar Footprint

The Group’s physical infrastructure comprises 43 manufacturing plants situated across five continents, 25 specialized formulation and chemistry R&D centers, and 39 dedicated seed research hubs across 12 countries. In India, primary active ingredient synthesis complexes are concentrated within the industrial corridors of Gujarat (Ankleshwar, Vapi, Dahej, Jhagadia), Maharashtra, Jammu, Karnataka, and West Bengal.

This industrial footprint is supported by three centralized Global Capability Centres (GCCs) located in Pune (India), Bogotá (Colombia), and Port Louis (Mauritius). Operating on a 24×7 basis with over 500 professionals, these capability hubs centralize back-office transaction processing, global human resources, supply chain analytics, IT systems, and legal compliance workflows, enabling regional field sales teams to focus on market execution.

📊 The Financial Health: The Numbers Simplified

The financial turnaround in FY 2025-26 was marked by disciplined capital allocation, working capital optimization, and debt reduction. The multi-year performance summary demonstrates a structural recovery following the cyclical trough of FY 2023-24.

Financial Metric (₹ in Crores unless stated) FY 2021-22 FY 2022-23 FY 2023-24 FY 2024-25 FY 2025-26 Latest YoY (%)
Revenue from Operations 46,240 53,576 43,098 46,637 51,839 +11.15%
EBITDA 10,165 11,178 5,515 8,124 9,588 +18.02%
EBITDA Margin (%) 22.0% 20.9% 12.8% 17.4% 18.5% –
Net Profit (PAT before Associate, NCI & Exceptional) 4,427 4,627 (1,383) 820.00 2,220.00 +170.73%
PAT Margin (%) 9.6% 8.3% (3.2%) 3.6% 4.5% –
Basic EPS (₹ per share) 45.9 45.8 (17.5)^ 9.7 22.3 +129.90%
Fixed Assets 18,906 19,538 19,631 20,727 20,906 +0.86%
Net Worth / Total Equity Attributable to Owners 24,807 26,858 21,675 29,213 34,696 +18.77%
Net Debt (including Perpetual Bonds in FY25) 16,902 13,858 20,572 22,174 15,325 -30.89%
Net Debt to EBITDA (x) 1.7x 1.5x 4.0x 1.9x 1.6x -15.79%
Return on Capital Employed (ROCE %) 15.6% 15.3% 4.9% 9.04% 10.49% –
Cash Generated from Operations 7,751 6,496 1,822 10,151 7,855 -22.62%

^Note: FY24 EPS restated on account of the rights issue as per Ind AS 33.

Earnings, Expenses, & Take-Home Profits

Consolidated revenue from operations expanded 11.15% to ₹51,839 crore in FY 2025-26, supported by an 8% volume growth across key international agricultural corridors. Gross contribution increased 17% to ₹213.38 crore, yielding a 220 basis point margin expansion to 41.2% as a result of lower raw material procurement costs and higher capacity utilisation across chemical technical plants.

Operating EBITDA rose 18.02% to ₹9,588 crore. Enhanced operational discipline below the EBITDA line, combined with lower interest expenses and currency stability, resulted in a 280.82% surge in Consolidated Profit Before Tax to ₹3,157 crore. Net Profit Attributable to the Owners of the Parent climbed 114.27% to ₹1,922 crore, while operational PATMI reached ₹1,860 crore.

Consolidated Statement of Profit and Loss Line Item (Ind AS Schedule III) FY 2025-26 (₹ in Crores) FY 2024-25 (₹ in Crores) Latest YoY (%)
Revenue from operations 51,839 46,637 +11.15%
Other income 663 486 +36.42%
Total Income 52,502 47,123 +11.41%
Cost of Raw materials and packing materials consumed 23,928 18,289 +30.83%
Purchases of stock-in-trade 3,808 4,208 -9.51%
Changes in inventory of finished goods, work-in-progress, and stock-in-trade (1,845) 1,726 N/M
Employee benefits expense 5,807 5,309 +9.38%
Finance costs 3,401 3,627 -6.23%
Depreciation and amortisation expense 3,244 2,750 +17.96%
Impairment loss on financial assets (net) 750 240 +212.50%
Exchange Difference (net) on trade receivables, trade payables, etc. 316 520 -39.23%
Other expenses 9,803 8,745 +12.10%
Total Expenses 49,212 45,414 +8.36%
Profit before share of loss of associates and joint ventures, exceptional items and tax 3,290 1,709 +92.51%
Share of loss of associates and joint ventures, net of tax (194) (472) -58.90%
Profit before exceptional items and tax 3,096 1,237 +150.28%
Exceptional items – (gain) / loss (net) (61) 408 N/M
Profit before tax 3,157 829 +280.82%
Current tax 1,304 848 +53.77%
Adjustments of tax relating to earlier years (61) (553) -88.97%
Deferred tax (306) (286) +6.99%
Total Tax Expenses 937 9 +10311.11%
Profit for the year 2,220 820 +170.73%
Total Other Comprehensive Income for the year, net of tax 3,573 42 +8407.14%
Total Comprehensive Income for the year 5,793 862 +572.04%
Profit Attributable to: Owners of the Parent 1,922 897 +114.27%
Profit Attributable to: Non-controlling interests 298 (77) N/M
Total Comprehensive Income Attributable to: Owners of the parent 4,676 960 +387.08%
Total Comprehensive Income Attributable to: Non-controlling interests 1,117 (98) N/M
Basic Earnings Per Equity Share (₹) 22.32 9.66 +131.06%
Diluted Earnings Per Equity Share (₹) 22.32 9.62 +132.02%

Assets, Borrowings, & Net Worth

The consolidated balance sheet of UPL expanded to ₹95,205 crore as of March 31, 2026, compared to ₹88,002 crore in the previous fiscal year. Total equity attributable to the owners of the parent grew 18.77% to ₹34,696 crore, reinforced by retained operational profits, comprehensive foreign currency translation reserves, and the completion of calls on the rights issue shares.

Gross non-current and current borrowings declined to ₹22,046 crore, while net debt dropped to ₹15,325 crore. The capital structure was strengthened by the full redemption of the $400 million perpetual subordinated capital securities in May 2025, which were funded entirely via internal cash accruals.

Consolidated Balance Sheet Line Item (Ind AS Schedule III) As at March 31, 2026 (₹ in Crores) As at March 31, 2025 (₹ in Crores) Latest YoY (%)
Property, plant and equipment 8,474 8,107 +4.53%
Capital work-in-progress 999 615 +62.44%
Right of use assets 1,440 1,324 +8.76%
Goodwill 22,954 20,675 +11.02%
Other intangible assets 9,285 8,978 +3.42%
Intangible assets under development 2,148 1,931 +11.24%
Investments accounted for using the equity method 1,262 1,394 -9.47%
Financial Assets: Investments 770 614 +25.41%
Financial Assets: Trade receivables 469 7 +6600.00%
Financial Assets: Loans – 21 –
Financial Assets: Other financial assets 270 216 +25.00%
Deferred tax assets (net) 3,929 3,322 +18.27%
Other tax assets (net) 497 923 -46.15%
Other non-current assets 413 214 +92.99%
Total Non-Current Assets 52,910 48,341 +9.45%
Inventories 12,676 10,316 +22.88%
Financial Assets: Investments 634 320 +98.12%
Financial Assets: Trade receivables 17,874 15,505 +15.28%
Financial Assets: Cash and cash equivalents 5,975 9,478 -36.96%
Financial Assets: Bank balances other than Cash and cash equivalents 111 59 +88.14%
Financial Assets: Loans 203 25 +712.00%
Financial Assets: Other financial assets 1,027 746 +37.67%
Current tax assets (net) 415 341 +21.70%
Other current assets 3,247 2,827 +14.86%
Total Current Assets 42,162 39,617 +6.42%
Assets classified as held for sale 133 44 +202.27%
Total Assets 95,205 88,002 +8.19%
Equity share capital 169 159 +6.29%
Other equity 34,527 29,054 +18.84%
Equity attributable to owners of the Parent 34,696 29,213 +18.77%
Non-controlling interests 6,573 5,627 +16.81%
Non-controlling interests – Perpetual subordinated capital securities – 2,986 –
Total Non-controlling interests 6,573 8,613 -23.69%
Total Equity 41,269 37,826 +9.10%
Financial Liabilities: Borrowings 15,535 18,263 -14.94%
Financial Liabilities: Lease liabilities 1,021 993 +2.82%
Financial Liabilities: Other financial liabilities 30 26 +15.38%
Provisions 423 335 +26.27%
Deferred tax liabilities (net) 2,086 1,990 +4.82%
Other non-current liabilities 93 – –
Total Non-Current Liabilities 19,188 21,607 -11.20%
Financial Liabilities: Borrowings 6,511 5,451 +19.45%
Financial Liabilities: Lease liabilities 509 392 +29.85%
Financial Liabilities: Trade payables – Micro and Small enterprises 34 38 -10.53%
Financial Liabilities: Trade payables – Other than Micro and Small enterprises 11,984 10,829 +10.67%
Financial Liabilities: Rebate and refund liabilities 5,084 3,781 +34.46%
Financial Liabilities: Other financial liabilities 3,663 2,919 +25.49%
Other current liabilities 5,809 4,390 +32.32%
Provisions 333 269 +23.79%
Current tax liabilities (net) 821 500 +64.20%
Total Current Liabilities 34,748 28,569 +21.63%
Total Liabilities 53,936 50,176 +7.49%
Total Equity and Liabilities 95,205 88,002 +8.19%

Cash Flow: Tracking the Money Movement

Cash generated from operations stood at ₹8,426 crore, yielding net operating cash flows of ₹7,855 crore after net income taxes paid of ₹571 crore. Working capital cash movements reflected an inventory expansion of ₹2,360 crore to support seasonal deliveries, offset by an increase in operational trade and other payables of ₹5,687 crore. Net working capital cycle closed at 57 days compared to 53 days in FY 2024-25.

Net cash used in financing activities reached ₹9,883 crore, driven by gross non-current debt repayments of ₹4,742 crore, full redemption of perpetual bonds amounting to ₹3,409 crore, and net finance charges paid of ₹2,879 crore. Financing outflows were partially funded by ₹1,700 crore in proceeds from the second and final call of the rights issue.

Consolidated Statement of Cash Flows (Ind AS Schedule III) FY 2025-26 (₹ in Crores) FY 2024-25 (₹ in Crores) Latest YoY (%)
Profit before tax 3,157 829 +280.82%
Depreciation and amortisation expenses 3,244 2,750 +17.96%
Finance costs 3,401 3,627 -6.23%
Impairment loss on financial assets 750 240 +212.50%
Assets written off 9 10 -10.00%
Gain on sale of property, plant and equipment (net) (9) (61) -85.25%
Interest income on loans and others (496) (346) +43.35%
Unwinding of interest on trade payables and trade receivables (474) (340) +39.41%
Excess provisions in respect of earlier years written back (net) (2) (27) -92.59%
Share based payments 70 39 +79.49%
Share of loss of associates and joint ventures (net of tax) 194 472 -58.90%
Exceptional items – (gain) / loss (net) (208) 264 N/M
Profit on sale of Investment (net) (27) (25) +8.00%
Fair value (gain)/loss on financial instruments at FVTPL (10) 5 N/M
Operating profit before working capital changes 9,599 7,437 +29.07%
(Increase) / Decrease in Inventories (2,360) 2,460 N/M
(Increase) / Decrease in trade receivables and other assets (4,500) 560 N/M
Increase in trade and other payables 5,687 677 +740.03%
Cash generated from operations 8,426 11,134 -24.32%
Income taxes paid (net) (571) (983) -41.91%
Net cash generated from operating activities (A) 7,855 10,151 -22.62%
Purchase of Property, plant and equipment including CWIP and capital advances (1,666) (813) +104.92%
Purchase of intangible assets including assets under development (740) (882) -16.10%
Proceeds from sale of property, plant and equipment 10.49% 9.04% –
Payment of deferred liabilities (207) (185) +11.89%
Investment in associates and joint ventures (22) (680) -96.76%
Purchase of non-current investments (65) (9) +622.22%
Proceeds from sale of non current investments 10.49% 9.04% –
Purchase of current investments (net) (313) (48) +552.08%
Sundry loans (given) / received back (162) (17) +852.94%
(Investments in) / Proceeds from Fixed deposit and margin money, earmarked balances (net) (52) 34 N/M
Dividend received from associates and joint ventures 275 21 +1209.52%
Interest received 512 299 +71.24%
Net cash used in investing activities (B) (2,362) (1,840) +28.37%
Repayment of non-current borrowings (4,742) (2,137) +121.90%
Proceeds / (repayment) from current borrowings (net) 10.49% 9.04% –
Repayment of Perpetual bond (3,409) – –
Proceeds from right issue (net of share issue expenses) 10.49% 9.04% –
Interest paid and other financial charges (2,879) (3,328) -13.49%
Repayment of lease liabilities (including Interest) (641) (530) +20.94%
Proceeds from equity dilution in subsidiaries (net of expenses) 10.49% 9.04% –
Dividend paid to non-controlling interest by subsidiaries (9) – –
Dividend paid (478) (77) +520.78%
Net cash used in financing activities (C) (9,883) (4,793) +106.20%
Effect of foreign exchange on cash & cash equivalents (D) 887 17 +5117.65%
Net (decrease) / increase in cash and cash equivalents (A+B+C+D) (3,503) 3,535 N/M
Cash and cash equivalents as at the beginning of the year 9,478 5,943 +59.48%
Cash and cash equivalents as at the end of the year 5,975 9,478 -36.96%

Funding the Future: CapEx, CWIP & R&D Spending

Total capital expenditure additions across property, plant, and equipment and intangible assets reached $261 million (₹2,406 crore on a consolidated segment addition basis). Capital Work-in-Progress (CWIP) closed at ₹999 crore, consisting of brownfield expansions in backward-integrated active ingredient units, continuous flow chemical synthesis reactors, and high-efficiency formulation packing lines.

Intangible assets under development stood at ₹2,148 crore, representing regulatory dossiers, field safety trials, and toxicology studies for new active ingredient registrations globally. Consolidated research and development spending rose to ₹15.34 crore (₹1,439 crore recurring and ₹0.95 crore capital), representing 2.95% of consolidated turnover, compared to 2.60% (₹12.13 crore) in FY 2024-25.

  • Flow Chemistry and Miniaturization: Deployment of continuous flow reactors and micro-reactor technologies across technical synthesis plants to lower energy intensity, enhance chemical reaction yields, and compress manufacturing cycle times.
  • Intangible Development Pipeline: 27 new active molecules and biological solutions in active development, supported by 17 platform solutions targeting commercial launch over the medium term.
  • Technology Importation & Absorption: Mechanically completed continuous phosgenation technology for 3,4-Dichlorophenyl Isocyanate (3,4-DCPI), with commercial operational stabilization scheduled for August–September 2026.

🗺️ The Corporate Family Tree: Structure & Investments

Subsidiaries, Associates, & Joint Ventures (Form AOC-1)

As of March 31, 2026, UPL Limited’s corporate network comprised 223 subsidiary, associate, and joint venture entities globally, which handle local chemical registrations, regional seed distribution, and regional marketing operations.

During the fiscal year, five new entities were incorporated or acquired: Advanta Seeds (Wuhan) Company Ltd (China), Agrovia LLC (United States), Grow Chemical Co Ltd. (Thailand), Advanta Seeds Vietnam Company Limited (Vietnam), and UPL GCC LATAM S.A.S (Colombia). Seven entities ceased operations through mergers, liquidations, or divestments: Arysta Agro Private Limited (India), Prolong Limited (Israel), Hannaford Nurture Farm Exchange Pty Ltd (Australia), UPL Agricultural Solutions Italy SRL (Italy), Arysta LifeScience Services LLP (India), Arysta LifeScience Mexico, S.A. de C.V. (Mexico), and Desarrollos Inmobiliarios Alianza de Coahuila, S.A. de C.V. (Mexico).

Entity Name Jurisdiction / Relationship % Equity Interest Reported Turnover / Revenue (₹ in Crores) Profit / (Loss) After Tax (₹ in Crores)
UPL Corporation Limited (Consolidated) Cayman Islands / Material Subsidiary 78.00% (22% NCI) 38,439 (161)
Advanta Enterprises Limited (Consolidated) India / Material Subsidiary 78.21% (22% NCI) 6,837 1,319
UPL Sustainable Agri Solutions Limited India / Wholly-owned Subsidiary 100.00% 3,212 548 (EBITDA)
Superform Chemistries Limited India / Wholly-owned Subsidiary 100.00% 10,298 1,258 (EBITDA)
3SB Produtos Agricolas SA Brazil / Associate 45.00% 262 (51)
Sinova Inovacoes Agricolas S.A. Brazil / Associate 33.00% 441 47
Ho Semillas Holdings S.A. Argentina / Associate 39.00% 3,437 (492)
Serra Bonita Sementes S.A. Brazil / Associate 20.00% 859 (5)
Longreach Plant Breeders Management Pty Ltd Australia / Joint Venture 70.00% Disclosed under Note 41 Disclosed under Note 41
Augene Chemical Private Limited India / Joint Venture 50.00% Disclosed under Note 41 Disclosed under Note 41

Strategic Investments & Treasury Holdings

Total non-current and current investments accounted for under Ind AS stood at ₹26.66 crore (₹203.20 crore non-current and ₹634 crore current). Investments accounted for using the equity method stood at ₹1,262 crore, comprising ₹473 crore in Ho Semillas Holding S.A., ₹215 crore in Longreach Plant Breeders Management Pty Ltd, ₹1.73 crore in Orígeo Comércio de Produtos Agropecuários S.A., and ₹1.56 crore in 3SB Produtos Agrícolas SA.

Investments carried at Fair Value through Other Comprehensive Income (FVTOCI) totaled ₹284 crore, anchored by a ₹1.92 crore quoted stake in Ishihara Sangyo Kaisha Ltd. Investments carried at Fair Value through Profit and Loss (FVTPL) stood at ₹1,120 crore (₹506 crore non-current and ₹614 crore current mutual funds). This includes credit rights investments in Brazilian agricultural funding vehicles: FIDC UPL 1 (₹212 crore), FIDC UPL 2 (₹111 crore), and Farmtech UP Credit FIDC (₹0.51 crore).

👥 Power & Control: Who Pulls the Strings?

The Brain Trust: Board of Directors & Key Managerial Personnel (KMP)

The governance structure of UPL Limited is overseen by a 9-member Board of Directors, comprising one Executive Director, three Non-Executive Non-Independent Directors, and five Independent Directors (including three Independent Women Directors, representing 33.33% gender diversity). The Lead Independent Director is Mr. Suresh Kumar.

Name of Director / KMP Designation DIN / Membership No. Board Committees & Core Professional Expertise
Mr. Jaidev R. Shroff Chairman & Group CEO (Promoter) DIN: 00191050 Global Business & Economics, Strategy, Leadership, Industry Specific Experience. Over 34 years agrochemical industry experience.
Mr. Vikram R. Shroff Vice Chairman & Co-CEO (Promoter) DIN: 00191472 Chairman – CSR Committee; Member – Sustainability & Stakeholders Relationship Committees. Global Operations, Supply Chain.
Mr. Raj Tiwari Whole-Time Director & CEO – SUPERFORM DIN: 09772257 Member – CSR, RMC & SRC. Operations, Manufacturing, Chemical Engineering. Total Remuneration: ₹11.29 Crore in FY26.
Mr. Hardeep Singh Non-Executive Director DIN: 00088096 Member – Audit, NRC & Sustainability Committees. Agricultural Business, Corporate Strategy, Governance.
Mr. Suresh Kumar Lead Independent Director DIN: 00512630 Chairman – NRC; Member – Audit & CSR Committees. International Trade, Corporate Administration, Management.
Ms. Naina Lal Kidwai Independent Director DIN: 00017806 Chairperson – Sustainability & SRC; Member – Audit. Investment Banking, ESG, Corporate Governance. Re-appointed for second 5-year term.
Ms. Usha Monari Independent Director DIN: 08652684 Member – Audit & NRC Committees. Infrastructure Finance, Sustainable Development, Water & Environmental Systems.
Ms. M.V. Bhanumathi Independent Director DIN: 10172983 Chairperson – Audit Committee. Finance, Taxation, Audit, Regulatory Compliance.
Mr. S.K. Mohanty Independent Director DIN: 06690879 Chairman – Risk Management Committee; Member – Sustainability Committee. Securities Market Regulation, Financial Systems.
Mr. Bikash Prasad Group Chief Financial Officer (KMP) KMP Corporate Finance, Global Treasury, Capital Markets, M&A. Ratio to median remuneration: 66.78x.
Mr. Sandeep Deshmukh Company Secretary & Compliance Officer (KMP) ACS-10946 Secretarial Compliance, Corporate Law, SEBI Governance. Ratio to median remuneration: 24.07x.

Who Owns the Stock? Shareholding Pattern

As of March 31, 2026, the paid-up equity share capital of UPL Limited stood at ₹168.83 crore, consisting of 84,41,69,318 fully paid-up equity shares of face value of ₹2 each. During the fiscal year, calls were completed on the 9,38,25,955 rights equity shares originally issued in December 2024. A total of 9,35,61,677 shares were converted to fully paid-up status upon receipt of ₹1,671.79 crore on the Second and Final Call, while 2,64,278 partly paid shares were forfeited due to non-payment.

Shareholder Category No. of Fully Paid Equity Shares Held % of Issued Equity Share Capital
Promoter & Promoter Group 27,93,35,627 33.09%
Foreign Institutional Investors (FIIs / FPIs) & Foreign Portfolio Corps 29,19,98,168 34.59%
Domestic Institutional Investors (Mutual Funds, Insurance Companies, Banks, AIFs) 13,67,55,429 16.20%
Non-Institutional Public Retail & Individual Investors 9,54,21,560 11.30%
GDR Underlying Shares (Listed on Singapore / London Stock Exchanges) 4,06,58,534 4.82%
Total Shareholding 84,41,69,318 100.00%

Institutional public shareholders holding more than 1% of equity capital as of March 31, 2026, include the Life Insurance Corporation of India (4.51%), ICICI Prudential Multi-Asset Fund (2.49%), MFS International Growth Fund (1.66%), JP Morgan Chase Bank NA (1.32%), Vanguard International Value Fund (1.19%), SBI Life Insurance Co. Ltd (1.15%), Lazard Emerging Markets Equity Portfolio (1.14%), Seafarer Overseas Growth & Income Fund (1.12%), National Pension Service Managed by Panagora Asset Management (1.04%), and SBI Contra Fund (1.01%).

🎯 The Strategic Outlook: Future Plans & Potential Pitfalls

Competitive Advantages & Economic Moats

The competitive moat of UPL Limited is built upon backward integration, global commercial distribution, intellectual property defenses, and its multi-tier regulatory platform. With 43 manufacturing sites strategically positioned near customer bases and raw material sources, the Group produces its own active ingredients and chemical intermediaries, reducing reliance on third-party supply chains.

The company maintains more than 16,000 product registrations and holds over 3,200 granted patents. Over 30% of its crop protection portfolio is intellectual property protected, shielding the business from generic price erosion. This technical foundation is complemented by Advanta’s proprietary seed germplasm, built on 50 years of breeding data and protected traits including igrowth and aphix.

  • Intellectual Property & Innovation Rate: Increased consolidated crop protection innovation rate to 16% in FY26, with 80% of its $4.4 billion risk-adjusted peak sales pipeline aligned with differentiated and sustainable formulations.
  • Distribution & Channel Breadth: Direct market execution across 140 countries, supported in India by 25,000+ dealers, 60 regional depots, 400 Unimarts, and direct access to 3,00,000 indirect retailers.
  • Low-Cost Chemistry Synthesis: Scale positions in phosphorus handling, cynation, acrolein, and phosgenation create barriers to entry for competitors lacking integrated environmental compliance frameworks.

What Could Go Wrong? Key Challenges & Business Risks

The enterprise operates in an environment exposed to commodity price cycles, geopolitical events, weather disruptions, and regulatory shifts. Key risks identified under the company’s Enterprise Risk Management (ERM) framework and Integrated Risk Assessment Framework (IRAF) include:

  • West Asia Geopolitical Disruption: Navigational gridlocks in the Strait of Hormuz disrupt transit of globally traded nitrogen fertilizers, methanol, and chemical intermediates, creating supply bottlenecks and establishing elevated cost floors for raw chemical feedstock.
  • Chinese Capacity Overhang & Price Volatility: Persistent chemical overcapacity in mainland China keeps ex-factory pricing of commodity active ingredients low. Although the removal of Chinese export tax rebates and strict environmental approvals are stabilizing prices, sudden pricing drops from Chinese exporters remain an ongoing exposure.
  • Tariffs & Trade Bifurcation: Shifting tariff regimes between the US, China, and India require continuous supply chain reallocation. Changes in reciprocal-exempt materials and broadacre trade flows directly influence export margins.
  • Climate & Weather Risks: The recurrence of El Niño weather patterns introduces rainfall deficits in India, Australia, and Southeast Asia, while bringing excess moisture to South America. Excessive rains suppress spray application windows and increase retail product returns, as observed in India during Q2 FY26.
  • Foreign Currency Exchange Fluctuations: Operating across multiple volatile currencies, notably the Brazilian Real (BRL), Argentine Peso (ARS), and Euro against the USD and INR, exposes earnings to translation losses and liquidity adjustments in dealer networks.
  • Contingent Liabilities & Litigations: Notes to the accounts disclose provisions for litigation of ₹201 crore relating to indirect taxes and legal claims from the historical Arysta acquisition in Brazil, alongside pending tax matters and contractual disputes.

The Next Chapter: Growth & CapEx Initiatives

Management’s strategic roadmap for FY 2026-27 and through FY 2030 is focused on scaling high-margin, differentiated platforms, maintaining working capital discipline, and completing corporate restructuring to unlock platform valuations.

The group expects to commercialize more than 100 new products globally in FY 2026-27, advancing its innovation rate toward 18% with a stated target of exceeding 20% by FY30. Revenue from sustainable and biological solutions is targeted to approach $700 million in FY27 and $1 billion by FY31, supported by the global rollout of the Nuvita nutrient-use efficiency platform across the Americas and Asia.

  • Composite Scheme Execution: Finalizing statutory, NCLT, and regulatory approvals for the Composite Scheme of Arrangement to establish UPL Global Sustainable Agri Solutions Limited as an independently listed global crop protection platform.
  • Advanta Enterprises Public Listing: Advancing the Initial Public Offering of Advanta Enterprises Limited on NSE and BSE pursuant to the DRHP filed in January 2026, facilitating transparent market price discovery for the seeds and post-harvest platform.
  • SUPERFORM Industrial Pivot: Expanding high-margin contract manufacturing (CMO) and super specialty chemistries to capture 10–12% global market share in India’s expanding specialty chemical sector, targeting applications in battery materials, flame retardants, and lubricant additives.
  • Environmental Net-Zero Roadmap: Pursuing SBTi-approved sustainability targets to achieve a 60% reduction in specific water consumption, CO2 emissions intensity, and waste disposal by 2030 against the FY20 baseline (55% water, 39% CO2, and 55% waste reductions achieved by FY26).

The Verdict: Strategic Outlook & Conclusion

UPL Limited completed a turnaround in FY 2025-26, transitioning from a cyclical down-cycle into a disciplined, high-operating-leverage phase. By expanding consolidated revenue by 11% to ₹51,839 crore, expanding gross contribution margins by 220 basis points to 41.2%, and increasing EBITDA by 18% to ₹9,588 crore, the Group demonstrated structural earnings resilience despite challenging farm economics.

The reduction in gross debt by $850 million, the redemption of the $400 million perpetual bond from internal cash accruals, and the reduction of net debt-to-EBITDA gearing to 1.6x have improved balance sheet stability. As the proposed group reorganisation into distinct pure-play platforms progresses toward completion alongside the Advanta IPO, UPL is positioned to lower its cost of capital, sharpen managerial accountability, and capture commercial demand across global agriculture and advanced specialty chemistries.

Note: Financial ratios, margins, YoY growth percentages, and % revenue shares are calculated by IndianCompanies.in based on disclosed Ind AS financial statements.

Official Site: https://www.upl-ltd.com